Free Trial

Jacobs Levy Equity Management Inc. Acquires 67,414 Shares of Arteris, Inc. (NASDAQ:AIP)

Arteris logo with Computer and Technology background

Jacobs Levy Equity Management Inc. lifted its stake in shares of Arteris, Inc. (NASDAQ:AIP - Free Report) by 36.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 253,211 shares of the company's stock after purchasing an additional 67,414 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 0.63% of Arteris worth $1,955,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. US Bancorp DE acquired a new stake in shares of Arteris during the 3rd quarter worth approximately $34,000. The Manufacturers Life Insurance Company bought a new position in Arteris in the second quarter valued at approximately $86,000. Algert Global LLC acquired a new stake in Arteris during the 2nd quarter worth $115,000. MetLife Investment Management LLC raised its position in shares of Arteris by 129.1% during the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock valued at $131,000 after acquiring an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of Arteris in the 3rd quarter valued at $226,000. 64.36% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Rosenblatt Securities reaffirmed a "buy" rating and set a $15.00 price objective on shares of Arteris in a research note on Wednesday, November 6th.

View Our Latest Analysis on Arteris

Insider Activity

In related news, COO Laurent R. Moll sold 30,860 shares of the business's stock in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $6.95, for a total value of $214,477.00. Following the completion of the transaction, the chief operating officer now directly owns 501,120 shares in the company, valued at approximately $3,482,784. The trade was a 5.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Isabelle F. Geday sold 15,550 shares of the firm's stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $9.03, for a total transaction of $140,416.50. Following the sale, the director now owns 121,213 shares in the company, valued at $1,094,553.39. This trade represents a 11.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 103,321 shares of company stock valued at $801,119 in the last quarter. Company insiders own 33.70% of the company's stock.

Arteris Trading Up 1.4 %

NASDAQ:AIP traded up $0.12 during trading hours on Friday, hitting $8.99. The stock had a trading volume of 167,707 shares, compared to its average volume of 147,535. The business's 50 day moving average is $7.76 and its 200-day moving average is $7.77. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. The company has a market cap of $361.22 million, a price-to-earnings ratio of -9.36 and a beta of 1.25. Arteris, Inc. has a one year low of $4.83 and a one year high of $9.54.

About Arteris

(Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad)

Should you invest $1,000 in Arteris right now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

AVGO is up 30% since earnings: could Broadcom be the next member of the Magnificent Seven? Can it sustain this momentum or is a pullback on the horizon?

Related Videos

Why Meta Is Still a Top Stock Pick for 2025
Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines